HK1145506A1 - Peptides and their use - Google Patents

Peptides and their use

Info

Publication number
HK1145506A1
HK1145506A1 HK10112002.9A HK10112002A HK1145506A1 HK 1145506 A1 HK1145506 A1 HK 1145506A1 HK 10112002 A HK10112002 A HK 10112002A HK 1145506 A1 HK1145506 A1 HK 1145506A1
Authority
HK
Hong Kong
Prior art keywords
peptides
Prior art date
Application number
HK10112002.9A
Other languages
English (en)
Inventor
Deborah O'neil
Original Assignee
Novabiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novabiotics Ltd filed Critical Novabiotics Ltd
Publication of HK1145506A1 publication Critical patent/HK1145506A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
HK10112002.9A 2007-02-02 2010-12-22 Peptides and their use HK1145506A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89928307P 2007-02-02 2007-02-02
GBGB0702020.9A GB0702020D0 (en) 2007-02-02 2007-02-02 Peptides and their use

Publications (1)

Publication Number Publication Date
HK1145506A1 true HK1145506A1 (en) 2011-04-21

Family

ID=37891189

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10112002.9A HK1145506A1 (en) 2007-02-02 2010-12-22 Peptides and their use

Country Status (17)

Country Link
US (1) US9169290B2 (xx)
EP (2) EP2251348B1 (xx)
JP (2) JP2010517988A (xx)
CN (1) CN101679487B (xx)
AU (1) AU2008211789B2 (xx)
CA (1) CA2706744C (xx)
CY (1) CY1115140T1 (xx)
DK (1) DK2251348T3 (xx)
ES (1) ES2449615T3 (xx)
GB (1) GB0702020D0 (xx)
HK (1) HK1145506A1 (xx)
HR (1) HRP20140185T1 (xx)
NZ (1) NZ578970A (xx)
PL (1) PL2251348T3 (xx)
PT (1) PT2251348E (xx)
SI (1) SI2251348T1 (xx)
WO (1) WO2008093060A2 (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0702021D0 (en) 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
WO2009153418A1 (fr) * 2008-06-16 2009-12-23 Centre National De La Recherche Scientifique (C.N.R.S) Peptides harp inhibant la croissance tumorale
FR2941231B1 (fr) * 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
CN102432672A (zh) * 2011-12-13 2012-05-02 重庆理工大学 一组新型合成抗菌肽及其应用
GB201204457D0 (en) * 2012-03-14 2012-04-25 Novabiotics Ltd Polypeptides and their use
DK3677252T3 (da) 2012-03-19 2023-10-02 Cidara Therapeutics Inc Doseringsregimer for echinocandin-klasse forbindelser
CN106170491B (zh) * 2013-10-30 2020-07-24 阿尔杰妮卡治疗学有限公司 神经保护肽
GB201405891D0 (en) * 2014-04-02 2014-05-14 Novabiotics Ltd Modified antimicrobial peptides
RS59119B1 (sr) 2014-05-21 2019-09-30 Entrada Therapeutics Inc Peptidi koji prodiru u ćelije i postupci za njihovo pravljenje i upotrebu
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
EP3185880B1 (en) 2014-08-27 2020-02-12 Ohio State Innovation Foundation Improved peptidyl calcineurin inhibitors
WO2017034961A1 (en) * 2015-08-21 2017-03-02 Trilogy Therapeutics, Inc. Methods of treating lung infection with caspofungin
US10369188B2 (en) 2016-01-08 2019-08-06 Cidara Therapeutics, Inc. Methods for preventing and treating pneumocystis infections
EP4268896A3 (en) 2016-03-16 2024-01-03 Cidara Therapeutics, Inc. Dosing regimens for treatment of fungal infections
GB201609925D0 (en) * 2016-06-07 2016-07-20 Novabiotics Ltd Formulation
WO2018191692A1 (en) * 2017-04-14 2018-10-18 Cidara Therapeutics, Inc. Methods for treating fungal infections
JP2020529973A (ja) 2017-07-12 2020-10-15 シダラ セラピューティクス インコーポレーテッド 真菌感染症の処置のための組成物及び方法
US11576946B2 (en) 2018-01-29 2023-02-14 Ohio State Innovation Foundation Peptidyl inhibitors of calcineurin-NFAT interaction
TW201945014A (zh) 2018-02-22 2019-12-01 美商安卓達治療股份有限公司 用於治療粒線體性神經胃腸腦病變之組合物及方法
US11344614B2 (en) * 2018-09-29 2022-05-31 Emergex Vaccines Holding Ltd. Pharmaceutical compositions comprising dengue virus-specific multiple HLA-binding T cell epitopes
KR102429281B1 (ko) * 2020-05-25 2022-08-05 (주)노바셀테크놀로지 신규 안구건조증 치료용 약학적 조성물
GB202010268D0 (en) * 2020-07-03 2020-08-19 Novabiotics Ltd Nail formulations and treatment regimes
CN113336824A (zh) * 2021-04-30 2021-09-03 重庆理工大学 一种多肽在作为pd-1/pd-l1蛋白-蛋白相互作用(ppi)调节剂中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149254A3 (en) 1983-12-29 1987-01-28 The Research Foundation Of State University Of New York Fungicidal polypeptide compositions containing l-histidine
US5646120A (en) * 1990-10-24 1997-07-08 Allelix Biopharmaceuticals, Inc. Peptide-based inhibitors of HIV replication
EP0975370B9 (en) * 1997-05-21 2004-11-03 The Board Of Trustees Of The Leland Stanford Junior University Composition and method for enhancing transport across biological membranes
US8038984B2 (en) * 1998-06-20 2011-10-18 Washington University Membrane-permeant peptide complexes for treatment of sepsis
US7049395B2 (en) * 2000-05-02 2006-05-23 Yale University Anti-inflammatory compounds and uses thereof
US20040142892A1 (en) * 2001-04-30 2004-07-22 The University Of British Columbia Autogene nucleic acids encoding a secretable RNA polymerase
US7033991B2 (en) * 2001-07-16 2006-04-25 Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College Inhibiting furin with polybasic peptides
JP2005525998A (ja) * 2001-08-30 2005-09-02 プラエシス ファーマシューティカルズ インコーポレーテッド 炎症性疾患の治療のための方法および組成物
AU2003297657A1 (en) * 2002-11-29 2004-06-23 Adaptive Therapeutics, Inc. Antifungal therapeutic agents
US7125842B2 (en) * 2003-04-07 2006-10-24 Canbas Co. Ltd. Anti-fungal compounds and methods of use
US20050203892A1 (en) * 2004-03-02 2005-09-15 Jonathan Wesley Dynamically integrating disparate systems and providing secure data sharing
WO2006018652A2 (en) 2004-08-18 2006-02-23 Novabiotics Limited Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
CA2655448C (en) * 2005-12-22 2016-09-06 Novabiotics Limited Cyclic antimicrobial peptides
JP4520477B2 (ja) * 2006-10-31 2010-08-04 株式会社マルハニチロ食品 抗真菌ペプチドまたはそれを含有するペプチド組成物とその製造方法
GB0702021D0 (en) 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
GB0702022D0 (en) 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use

Also Published As

Publication number Publication date
ES2449615T3 (es) 2014-03-20
WO2008093060A2 (en) 2008-08-07
JP5882260B2 (ja) 2016-03-09
EP2251348B1 (en) 2014-01-15
JP2010517988A (ja) 2010-05-27
US20100184696A1 (en) 2010-07-22
NZ578970A (en) 2012-04-27
HRP20140185T1 (hr) 2014-05-09
CN101679487B (zh) 2018-04-03
US9169290B2 (en) 2015-10-27
SI2251348T1 (sl) 2014-05-30
PT2251348E (pt) 2014-03-06
GB0702020D0 (en) 2007-03-14
AU2008211789A1 (en) 2008-08-07
EP2114988A2 (en) 2009-11-11
JP2014012667A (ja) 2014-01-23
EP2251348A2 (en) 2010-11-17
DK2251348T3 (en) 2014-03-03
CA2706744C (en) 2017-12-05
EP2251348A3 (en) 2011-03-02
CA2706744A1 (en) 2008-08-07
WO2008093060A3 (en) 2008-10-23
CN101679487A (zh) 2010-03-24
PL2251348T3 (pl) 2014-05-30
CY1115140T1 (el) 2016-12-14
AU2008211789B2 (en) 2013-11-14

Similar Documents

Publication Publication Date Title
HK1145506A1 (en) Peptides and their use
EP2236514A4 (en) ARTIFICIAL PEPTIDE AND USE THEREOF
EP2142572A4 (en) TGFP CAP PEPTIDE AND APPLICATIONS THEREOF
IL205571A0 (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin
EP2370458A4 (en) PEPTIDES OF NEUREGULIN AND THEIR USE
HRP20150195T1 (xx) Antibakterijski peptidi
EP2185692A4 (en) HCO32 AND HCO27 AND RELATED EXAMPLES
EP1976864A4 (en) NEW PEPTIDE AND ITS USE
GB0712670D0 (en) Isolated peptides and uses thereof
EP2383283A4 (en) NOGGIN PEPTIDE AND ITS USE
EP2474555A4 (en) PEPTIDE DERIVED FROM WNT10 AND USE THEREOF
GB0708376D0 (en) Novel polypeptides and uses thereof
GB0702022D0 (en) Peptides and their use
IL195525A0 (en) Replikin peptides and uses thereof
GB0604187D0 (en) Peptide and uses thereof
GB2460178B (en) Depsipeptides and their therapeutic use
HK1168363A1 (en) Novel peptide and use thereof
EP2285827A4 (en) PEPTIDES AND ITS USE
GB0908875D0 (en) Depsipeptides and their therapeutic use
EP2239267A4 (en) TAG PEPTIDE AND ITS USE
PL2222692T3 (pl) Syntetyczny peptyd wiążący się z ludzkim CD154 i jego zastosowania
EP2133326A4 (en) NEW PSEUDOGLYCOLIPID AND ITS USE
EP2450374A4 (en) PEPTIDE AND ITS USE
GB2460180B (en) Depsipeptides and their therapeutic use
GB0617564D0 (en) Peptides and methods